CRYM (Cryomass Technologies) Gross Margin %: 0.00% (As of Sep. 2024)


What is Cryomass Technologies Gross Margin %?

Cryomass Technologies CRYM -99.50% Gross Margin % is 0.00% as of Sep. 2024.

Gross Margin % is calculated as gross profit divided by its revenue. Cryomass Technologies's Gross Profit for the three months ended in Sep. 2024 was $0.01 Mil. Cryomass Technologies's Revenue for the three months ended in Sep. 2024 was $0.01 Mil. Therefore, Cryomass Technologies's Gross Margin % for the quarter that ended in Sep. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Cryomass Technologies's Gross Margin % or its related term are showing as below:


CRYM's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 48.54
* Ranked among companies with meaningful Gross Margin % only.

Cryomass Technologies had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Cryomass Technologies was 0.00% per year.

Cryomass Technologies  (OTCPK:CRYM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cryomass Technologies had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Cryomass Technologies Gross Margin % Related Terms

Cryomass Technologies Gross Margin % Historical Data

* Premium members only.

The historical data trend for Cryomass Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryomass Technologies Gross Margin % Chart

Cryomass Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,005.56 4.74 0.00 0.00 0.00

Cryomass Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CRYM vs PNXP, SKYI, ABTI: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryomass Technologies Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's Gross Margin % falls into.


Cryomass Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Cryomass Technologies's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0 / 0.014
=(Revenue - Cost of Goods Sold) / Revenue
=(0.014 - 0) / 0.014
=N/A %

Cryomass Technologies's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=0 / 0.005
=(Revenue - Cost of Goods Sold) / Revenue
=(0.005 - 0) / 0.005
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Cryomass Technologies (CRYM) has a Gross Margin % of 0.00% as of Sep. 2024. Gross margin is the ratio of total gross profit to net sales. View historical data on Cryomass Technologies and its competitors.
Is Cryomass Technologies' Gross Margin % too high?
Cryomass Technologies' current Gross Margin % is 0.00%.
How does Cryomass Technologies' Gross Margin % compare to PNXP and SKYI?
Cryomass Technologies' Gross Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cryomass Technologies and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryomass Technologies's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryomass Technologies stock overvalued right now?
Cryomass Technologies (CRYM) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cryomass Technologies (CRYM), the current Gross Margin % is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cryomass Technologies Business Description

Address 1001 Bannock Street, Suite 612, Denver, CO, USA, 80204
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect, and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.